INT ORTHOP 润色咨询

INTERNATIONAL ORTHOPAEDICS

出版年份:1977 年文章数:4822 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:20.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向:骨科<br>经验分享:投稿后第一天就回复让转投了,挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0<br>偏重的研究方向:骨科创伤;骨科临床研究<br>经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么<span class="quote">LiDh9090 2016-08-28 16:49:00 发表:<br>这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.</span>, beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0<br>偏重的研究方向:骨科<br>经验分享:投稿不到两月,目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2024-03-15 12023a71m61暂无昵称 来自新疆

    很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向:骨科<br>经验分享:投稿后第一天就回复让转投了,挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0<br>偏重的研究方向:骨科创伤;骨科临床研究<br>经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么<span class="quote">LiDh9090 2016-08-28 16:49:00 发表:<br>这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.</span>, beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0<br>偏重的研究方向:骨科<br>经验分享:投稿不到两月,目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2023-12-01 ms1000001598442016 来自黑龙江省

    偏重的研究方向:骨科
    经验分享:投稿后第一天就回复让转投了,挺快

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向:骨科<br>经验分享:投稿后第一天就回复让转投了,挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0<br>偏重的研究方向:骨科创伤;骨科临床研究<br>经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么<span class="quote">LiDh9090 2016-08-28 16:49:00 发表:<br>这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.</span>, beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0<br>偏重的研究方向:骨科<br>经验分享:投稿不到两月,目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-05-01 146f3421m19(暂无昵称)

    审稿速度:12.0
    偏重的研究方向:骨科创伤;骨科临床研究
    经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。

    7

    展开7条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向:骨科<br>经验分享:投稿后第一天就回复让转投了,挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0<br>偏重的研究方向:骨科创伤;骨科临床研究<br>经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么<span class="quote">LiDh9090 2016-08-28 16:49:00 发表:<br>这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.</span>, beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0<br>偏重的研究方向:骨科<br>经验分享:投稿不到两月,目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-05-11 12312345567890

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向:骨科<br>经验分享:投稿后第一天就回复让转投了,挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0<br>偏重的研究方向:骨科创伤;骨科临床研究<br>经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么<span class="quote">LiDh9090 2016-08-28 16:49:00 发表:<br>这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.</span>, beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0<br>偏重的研究方向:骨科<br>经验分享:投稿不到两月,目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2016-09-30 memeclee

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向:骨科<br>经验分享:投稿后第一天就回复让转投了,挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0<br>偏重的研究方向:骨科创伤;骨科临床研究<br>经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么<span class="quote">LiDh9090 2016-08-28 16:49:00 发表:<br>这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.</span>, beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0<br>偏重的研究方向:骨科<br>经验分享:投稿不到两月,目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2017-09-02 carl97

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向:骨科<br>经验分享:投稿后第一天就回复让转投了,挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0<br>偏重的研究方向:骨科创伤;骨科临床研究<br>经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么<span class="quote">LiDh9090 2016-08-28 16:49:00 发表:<br>这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.</span>, beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0<br>偏重的研究方向:骨科<br>经验分享:投稿不到两月,目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2018-01-03 1e16609dm11(暂无匿称)

    请问要meta么LiDh9090 2016-08-28 16:49:00 发表:
    这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.

    LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向:骨科<br>经验分享:投稿后第一天就回复让转投了,挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0<br>偏重的研究方向:骨科创伤;骨科临床研究<br>经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么<span class="quote">LiDh9090 2016-08-28 16:49:00 发表:<br>这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.</span>, beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0<br>偏重的研究方向:骨科<br>经验分享:投稿不到两月,目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2021-09-25 ms3000000534700024

    审稿速度:2.0
    偏重的研究方向:骨科
    经验分享:投稿不到两月,目前已接收

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向:骨科<br>经验分享:投稿后第一天就回复让转投了,挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0<br>偏重的研究方向:骨科创伤;骨科临床研究<br>经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么<span class="quote">LiDh9090 2016-08-28 16:49:00 发表:<br>这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.</span>, beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0<br>偏重的研究方向:骨科<br>经验分享:投稿不到两月,目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-06-16 ms6000001522264603

    请问接受骨质疏松方向文章吗

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2193497, encodeId=0975219349e37, content=很不愉快的一次投稿经历,投稿后1个月小修,审稿人建议接收,主编给了一个小小的意见。稳妥起见,查阅大量了一些文献后,对文章进行了仔细修改。修回后第二天,直接拒稿,说是稿件质量不高,不符合初审标准,建议转投脊柱外科专科期刊!气得我连夜进行了申诉,一周内发了三次申诉信,但是并未得到任何回应!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc092157049, createdName=12023a71m61暂无昵称, createdTime=Fri Mar 15 21:20:49 CST 2024, time=2024-03-15, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2172362, encodeId=f65a21e2362da, content=偏重的研究方向:骨科<br>经验分享:投稿后第一天就回复让转投了,挺快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37f05470775, createdName=ms1000001598442016, createdTime=Fri Dec 01 16:14:48 CST 2023, time=2023-12-01, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0<br>偏重的研究方向:骨科创伤;骨科临床研究<br>经验分享:一审9个月,差点撤稿;Major Revision两个月后accept,提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218899, encodeId=e3661218899a8, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享:投了1篇,2小时拒稿,没有审稿意见,现在又投了另一篇在等回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c42942062, createdName=12312345567890, createdTime=Wed May 11 22:58:18 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527804, encodeId=0e4552e8045a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:初审很严格,质量不佳的基本秒拒,有一篇1天悲剧。另一篇,2月大修,意见友善,大修后1月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0b31959968, createdName=memeclee, createdTime=Fri Sep 30 20:57:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546223, encodeId=cdbf546223dc, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:这个杂志初审相对严格.基本拒稿会在投稿2_3天内.送审后录用概率比较大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64cc84021, createdName=carl97, createdTime=Sat Sep 02 16:34:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550584, encodeId=894355058441, content=请问要meta么<span class="quote">LiDh9090 2016-08-28 16:49:00 发表:<br>这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的.</span>, beContent=LiDh9090 2016-08-28 16:49:00 发表: 这个杂志初筛很严格.投过五篇.有幸中了两篇.都是两个月内就接受了.速度真心点赞!感觉编辑喜欢热点文章!帮忙审稿了3篇文章.都是据稿.感觉这个杂志上升空间还是有的., objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1ab1972988, createdName=1e16609dm11(暂无匿称), createdTime=Wed Jan 03 00:00:00 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0<br>偏重的研究方向:骨科<br>经验分享:投稿不到两月,目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226710, encodeId=dd591226e1036, content=请问接受骨质疏松方向文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234b5498982, createdName=ms6000001522264603, createdTime=Thu Jun 16 01:58:23 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209198, encodeId=5937120919884, content=该期刊要求的参考文献格式是endnote中的那种格式形式???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e08103049, createdName=ms8000000975709473, createdTime=Thu Apr 07 11:50:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-04-07 ms8000000975709473

    该期刊要求的参考文献格式是endnote中的那种格式形式???

    0

共169条页码: 1/17页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分